Cart
sales@molnova.com
XMD-17-51
CAS No. 1628614-50-5
XMD-17-51( XMD17-51 )
Catalog No. M23725 CAS No. 1628614-50-5
XMD-17-51 is a potent and highly selective NUAK1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | In Stock |
|
| 50MG | 1782 | In Stock |
|
| 100MG | 2250 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXMD-17-51
-
NoteResearch use only, not for human use.
-
Brief DescriptionXMD-17-51 is a potent and highly selective NUAK1 inhibitor.
-
DescriptionXMD-17-51 is a potent and highly selective NUAK1 inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsXMD17-51
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorNUAK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1628614-50-5
-
Formula Weight404.47
-
Molecular FormulaC21H24N8O
-
Purity>98% (HPLC)
-
SolubilityDMSO:75 mg/ml (185.43 mM); Ethanol:10 mg/ml (24.72 mM); Water:2 mg/ml (4.94 mM)
-
SMILESO=C1N(C)C2=CN=C(NC3=CN(C4CCNCC4)N=C3)N=C2N(C)C5=CC=CC=C15
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
YLF-466D
YLF-466D (C24) is a novel AMPK activator that inhibits platelet aggregation.
-
Onjisaponin B
Onjisaponin B induces autophagy via the AMPK-mTOR signaling pathway, increases the NGF level and accelerates both the removal of mutant huntingtin and A53T α±-synuclein, it may have potential therapeutic effects on Parkinson disease, Alzheimer disease and Huntington disease.
-
Metformin
Metformin is an AMP-activated protein kinase (AMPK) activator that improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose.
